Patients with acromegaly make too much growth hormone, which causes them to grow disproportionately large bones, organs and ...

These include people growing abnormally tall, hormonal problems and infertility. In many cases it is disfiguring but it can also be life-threatening. The condition, called acromegaly or gigantism ...

Biochemical control of acromegaly in noncured patients is usually defined as serum growth hormone (GH) levels <2.0 µg/l, plus normal-for-age serum levels of insulin-like growth factor I (IGF-I).

Paltusotine was granted Orphan Drug Designation for the treatment of acromegaly by the FDA in July 2020. This designation is provided to drugs defined as being intended for the safe and effective ...

Patients with acromegaly require fortnightly or monthly ... All injectors in the test group (12 of whom were the patients and 3 were other people) were successfully trained to inject without ...